Nuwellis (Nasdaq:NUWE) announced today that it entered into a supply and collaboration agreement with DaVita (NYSE:DVA). The agreement enables Nuwellis — formerly CHF Solutions — to pilot its Aquadex ultrafiltration therapy within selected U.S. markets. Aquadex, which removes excess fluid from patients suffering from hypervolemia (fluid overload), treats congestive heart failure and related conditions. DaVita […]
Nuwellis
SeaStar Medical, Nuwellis partner on kidney injury treatment
SeaStar Medical (Nasdaq:ICU) and Nuwellis (Nasdaq:NUWE) today announced an exclusive U.S. license and distribution agreement. Nuwellis agreed to market and distribute SeaStar’s selective cytopheretic device (SCD). The SCD treats acute kidney injury (AKI) in children. It selectively targets the most activated pro-inflammatory neutrophils and monocytes to stop cytokine storm. The system works with continuous kidney […]
Nuwellis announces compliance with Nasdaq listing requirements
Nuwellis (Nasdaq:NUWE) announced that it received notice from the Nasdaq market that it regained compliance with certain requirements. Minneapolis-based Nuwellis last month received a 180-day extension from Nasdaq to regain compliance. That followed a 180-day period in which the company failed to do so. Nasdaq granted the company time until May 29, 2023, to get […]
Nuwellis can’t get a quorum for shareholder vote
Nuwellis (Nasdaq:NUWE) announced today that it convened and adjourned its meeting of stockholders due to a failure to reach a quorum. The fluid overload treatment developer held the meeting on Dec. 7 without any business conducted due to the lack of quorum. Minneapolis-based Nuwellis develops the Aquadex SmartFlow system for ultrafiltration therapy. The company describes […]
Nasdaq grants Nuwellis 180-day extension to comply with listing requirement
Nuwellis (Nasdaq:NUWE) announced today that the Nasdaq market granted it a 180-day extension to regain compliance. Minneapolis-based Nuwellis must comply with the market’s minimum $1 bid price requirement for continued listing. The extension of 180 calendar days follows the expiration of its initial 180-day period to regain compliance on Nov. 28. As a result, Nuwellis […]
Nuwellis appoints new CFO following $11M public offering
Nuwellis (Nasdaq:NUWE) today announced it appointed Lynn Blake as chief financial officer on news that it closed an $11 million underwritten public offering. Blake’s appointment is effective immediately. She brings more than two decades of senior financial leadership to the Minneapolis-based company. “Nuwellis is entering our next phase of commercial development with significant new opportunities in […]
Nuwellis prices $9.6M upsized offering
Nuwellis (Nasdaq:NUWE) announced today that it priced an underwritten public offering worth approximately $9.6 million. The Minneapolis-based fluid overload treatment developer formerly operated as CHF Solutions. Nuwellis is offering preferred stock, common stock and warrants. It expects gross proceeds to total $9.6 million before deducting discounts, commissions and offering expenses, according to a news release. […]
Nuwellis posts Q2 sales beat
Nuwellis (Nasdaq:NUWE) shares were down today on second-quarter results that beat the consensus revenue forecast. The Minneapolis-based fluid overload treatment developer — formerly known as CHF Solutions — posted losses of $4.3 million, or 41¢ per share, on sales of $2.2 million for the three months ended June 30, 2022, for a slight bottom-line gain […]
Nuwellis rises on Street-beating Q1
Nuwellis (Nasdaq:NUWE) shares ticked up today on first-quarter results that topped the consensus forecast. The Minneapolis-based fluid overload treatment developer — formerly known as CHF Solutions — posted losses of $4.5 million, or 42¢ per share, on sales of more than $1.9 million for the three months ended March 31, 2022, for a bottom-line from […]
Nuwellis posts mixed bag Q4
Nuwellis (NSDQ:NUWE) shares were up today on fourth-quarter results that were mixed compared to the consensus forecast. The Minneapolis-based fluid overload treatment developer — formerly known as CHF Solutions — posted losses of $4.4 million, or 41¢ per share, on sales of $1.6 million for the three months ended Dec. 31, 2021, for a bottom-line […]
Nuwellis wins CE mark for 24-hour blood circuit set for use with Aquadex SmartFlow
Nuwellis (NSDQ:NUWE) announced today that it received CE mark approval for its 24-hour blood circuit set for use with the Aquadex SmartFlow. Eden Prairie, Minnesota-based Nuwellis — formerly CHF Solutions — can now market the 24-hour blood circuit set (UF 500-24 Hour) in the European Union and other locations that recognize the CE mark. According […]
